THE NEW SURGICAL PATIENT IN THE ERA OF GLP-1 RECEPTOR AGONISTS: PERIOPERATIVE IMPLICATIONS AND EMERGING CHALLENGES FOR ABDOMINAL SURGERY
The use of glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes mellitus and now widely prescribed for obesity, has changed the profile of patients referred for surgery. These agents produce substantial weight loss, but they also delay gastric emptying and are associated with bili...